Acebutolol Hydrochloride NDC 62559-255

NDC codes

FDA NDC Directory

Product NDC (as listed)62559-255Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62559-0255Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62559-255-01	62559025501	100 CAPSULE in 1 BOTTLE (62559-255-01)Marketed from Jul 25, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acebutolol Hydrochloride
Generic name (nonproprietary): acebutolol hydrochloride
Active ingredients: Acebutolol hydrochloride — 200 mg/1
Dosage form: Capsule
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074007
Marketing start: Jul 25, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 62559-255_512c2032-4b9a-4b8c-b360-02f89d62714cSPL ID 512c2032-4b9a-4b8c-b360-02f89d62714cSPL set ID 48bded12-09c7-47f2-b162-ec970a77f2d8RxCUI 998685, 998689UNII B025Y34C54UPC 0362559255011, 0362559256018
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462559025501 followed by a unit qualifier and the quantity

Package 62559-0255-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 7, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hypertension Acebutolol Hydrochloride Capsules USP are indicated for the management of hypertension in adults. It may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. Ventricular Arrhythmias Acebutolol Hydrochloride Capsules USP are indicated in the management of ventricular premature beats; it reduces the total number of premature beats, as well as the number of paired and multiform ventricular ectopic beats, and R-on-T beats.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074007

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074007
Product	Strength	Form · route	Labeler	Product NDC
Acebutolol Hydrochloride	Acebutolol hydrochloride 200 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-666
Acebutolol Hydrochloride	Acebutolol hydrochloride 400 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-667
Acebutolol Hydrochloride	Acebutolol hydrochloride 400 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	62559-256